Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-290436
Filing Date
2011-11-01
Accepted
2011-11-01 14:16:10
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d245706d10q.htm 10-Q 867558
2 CERTIFICATION OF PRESIDENT AND CHIEF EXECUTIVE OFFICER d245706dex311.htm EX-31.1 6914
3 CERTIFICATION OF EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER d245706dex312.htm EX-31.2 6977
4 CERTIFICATION OF PRESIDENT AND CHIEF EXECUTIVE OFFICER d245706dex321.htm EX-32.1 3859
5 CERTIFICATION OF EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER d245706dex322.htm EX-32.2 3910
  Complete submission text file 0001193125-11-290436.txt   6413261

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT wpi-20110930.xml EX-101.INS 1091396
7 XBRL TAXONOMY EXTENSION SCHEMA wpi-20110930.xsd EX-101.SCH 47934
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wpi-20110930_cal.xml EX-101.CAL 84150
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wpi-20110930_def.xml EX-101.DEF 168258
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE wpi-20110930_lab.xml EX-101.LAB 420632
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wpi-20110930_pre.xml EX-101.PRE 288477
Mailing Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054 9092701400
WATSON PHARMACEUTICALS INC (Filer) CIK: 0000884629 (see all company filings)

EIN.: 953872914 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13305 | Film No.: 111170729
SIC: 2834 Pharmaceutical Preparations